It is reported that CSV can be used as a target for capturing mesenchymal CTCs, and the rate of CTC detection by the CSV antibody is higher than that by the EpCAM antibody in breast and pancreatic cancer patients14,15. Here, EPCAM is linked to pancreatic neoplasm.